P35968 VGFR2_HUMAN

Gene name: KDR
Protein name: Vascular endothelial growth factor receptor 2

List of molecules and drugs that target protein P35968
# DrugDomain Data DrugBank Accession Name Drug action Affinity data InChI Key SMILES
1 P35968_DB00398 DB00398 Sorafenib antagonist Ki(nM) = 0.021
IC50(nM) = 0.06
Kd(nM) = 33.0
EC50(nM) = 500.0
MLDQJTXFUGDVEO-UHFFFAOYSA-N CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1
2 P35968_DB01268 DB01268 Sunitinib inhibitor Ki(nM) = 2.9
IC50(nM) = 0.4
Kd(nM) = 0.13
WINHZLLDWRZWRT-ATVHPVEESA-N CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
3 P35968_DB04727 DB04727 1-{4-[4-Amino-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-5-yl]phenyl}-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea n/a
FGZIONRFHVNRJB-UHFFFAOYSA-N COC1=CC=C(C=C1)C1=C(C2=C(N)N=CN=C2O1)C1=CC=C(NC(=O)NC2=C(F)C=CC(=C2)C(F)(F)F)C=C1
4 P35968_DB04849 DB04849 Cediranib n/a Ki(nM) = 0.5
IC50(nM) = 0.5
Kd(nM) = 1.1
XXJWYDDUDKYVKI-UHFFFAOYSA-N COC1=CC2=C(C=C1OCCCN1CCCC1)N=CN=C2OC1=C(F)C2=C(NC(C)=C2)C=C1
5 P35968_DB04879 DB04879 Vatalanib n/a IC50(nM) = 15.0
Kd(nM) = 62.0
YCOYDOIWSSHVCK-UHFFFAOYSA-N ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C3=CC=CC=C23)C=C1
6 P35968_DB05075 DB05075 TG-100801 n/a
JMGXJHWTVBGOKG-UHFFFAOYSA-N CC1=C2N=C(NC3=CC=C(OCCN4CCCC4)C=C3)N=NC2=CC(=C1)C1=CC(OC(=O)C2=CC=CC=C2)=CC=C1Cl
7 P35968_DB05984 DB05984 RAF-265 n/a
YABJJWZLRMPFSI-UHFFFAOYSA-N CN1C(NC2=CC=C(C=C2)C(F)(F)F)=NC2=CC(OC3=CC=NC(=C3)C3=NC=C(N3)C(F)(F)F)=CC=C12
8 P35968_DB06080 DB06080 Linifanib n/a
MPVGZUGXCQEXTM-UHFFFAOYSA-N CC1=CC(NC(=O)NC2=CC=C(C=C2)C2=C3C(N)=NNC3=CC=C2)=C(F)C=C1
9 P35968_DB06436 DB06436 Semaxanib n/a
WUWDLXZGHZSWQZ-WQLSENKSSA-N CC1=CC(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12
10 P35968_DB06589 DB06589 Pazopanib inhibitor IC50(nM) = 30.0
Kd(nM) = 14.0
CUIHSIWYWATEQL-UHFFFAOYSA-N CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1
11 P35968_DB06595 DB06595 Midostaurin antagonist
BMGQWWVMWDBQGC-IIFHNQTCSA-N CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1
12 P35968_DB06626 DB06626 Axitinib inhibitor
RITAVMQDGBJQJZ-FMIVXFBMSA-N CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
13 P35968_DB06938 DB06938 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide n/a Ki(nM) = 9.0
ZJLSMLDOCGOURY-UHFFFAOYSA-N CNC(=O)C1=NC=CC(OC2=CC3=C(C=C2)N=C(NC2=CC(=C(Cl)C=C2)C(F)(F)F)N3)=C1
14 P35968_DB07183 DB07183 N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide n/a Ki(nM) = 10.0
IC50(nM) = 38.0
CPVRYQAOUPSUDO-UHFFFAOYSA-N O=C(NC1=CC=C(OC2=CC=CC=C2)C=C1)C1=C(NCC2=CC=NC=C2)N=CC=C1
15 P35968_DB07274 DB07274 N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide n/a IC50(nM) = 0.6
ZATGFXTWDKIEKC-UHFFFAOYSA-N COC1=C(OC)C=C2C(OC3=CC4=CC=CC(C(=O)NC5CC5)=C4C=C3)=CC=NC2=C1
16 P35968_DB07326 DB07326 6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide n/a IC50(nM) = 353.0
FEGRQUWSKADGSP-UHFFFAOYSA-N FC(F)(F)C1=CC(NC2=NOC3=C(C(=O)NC4=CN=CN=C4)C(Cl)=CC=C23)=CC=C1
17 P35968_DB07333 DB07333 N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE n/a IC50(nM) = 38.0
KRGKAARWVPUWSY-UHFFFAOYSA-N COC1=CC=C(C=C1NC1=NC=C(O1)C1=CC(=CC=C1)C1=CN=CC=C1)S(=O)(=O)NCC1CC1
18 P35968_DB07334 DB07334 N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE n/a IC50(nM) = 17.0
HTIZPBXCJPQDEM-UHFFFAOYSA-N CCS(=O)(=O)C1=CC=C(OC)C(NC2=NC=C(O2)C2=CC=CC(=C2)C2=CC=CC=N2)=C1
19 P35968_DB07514 DB07514 3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one n/a IC50(nM) = 48.0
LHLGUOHREUTYTO-UHFFFAOYSA-N CC1=C(C(=O)N(C=C1)C1=CC=C2C(NCC2(C)C)=C1)C1=CC2=CN=C(N)N=C2C=C1
20 P35968_DB07528 DB07528 3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one n/a IC50(nM) = 5000.0
HXUZQEYFKAZBPX-UHFFFAOYSA-N CC1=C(C2=CC3=C(C=C2)N=C(N)N=C3)C(=O)N(C=C1)C1=CC(=CC=C1)C(F)(F)F
21 P35968_DB07537 DB07537 N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide n/a IC50(nM) = 25000.0
CLEGTVIMOPPIBR-UHFFFAOYSA-N CC1=CC=C(C=C1C(=O)NC1=CN=C(N)C=C1)C(=O)NCCC1CCCC1
22 P35968_DB08042 DB08042 N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine n/a
FLXGQDHYCWXTAI-UHFFFAOYSA-N COC1=CC(NC2=NC(=CC=N2)N(C)C2=CC3=C(C=C2)C(C)=NN3)=CC(OC)=C1OC
23 P35968_DB08519 DB08519 N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine n/a IC50(nM) = 6.3
SQQAPOSROFWHIB-UHFFFAOYSA-N COC1=CC(NC2=NC=CC(NC3=CC=C4C(C)=NNC4=C3)=N2)=CC(OC)=C1OC
24 P35968_DB08875 DB08875 Cabozantinib antagonist
ONIQOQHATWINJY-UHFFFAOYSA-N COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2
25 P35968_DB08896 DB08896 Regorafenib inhibitor Ki(nM) = 4.2
IC50(nM) = 4.0
FNHKPVJBJVTLMP-UHFFFAOYSA-N CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
26 P35968_DB08901 DB08901 Ponatinib inhibitor Ki(nM) = 1.5
IC50(nM) = 1.5
PHXJVRSECIGDHY-UHFFFAOYSA-N CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
27 P35968_DB09078 DB09078 Lenvatinib inhibitor
WOSKHXYHFSIKNG-UHFFFAOYSA-N COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O
28 P35968_DB09079 DB09079 Nintedanib inhibitor
XZXHXSATPCNXJR-ZIADKAODSA-N COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1
29 P35968_DB11800 DB11800 Tivozanib inhibitor
SPMVMDHWKHCIDT-UHFFFAOYSA-N COC1=C(OC)C=C2C(OC3=CC(Cl)=C(NC(=O)NC4=NOC(C)=C4)C=C3)=CC=NC2=C1
30 P35968_DB12010 DB12010 Fostamatinib inhibitor
GKDRMWXFWHEQQT-UHFFFAOYSA-N COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
31 P35968_DB12147 DB12147 Erdafitinib substrate
OLAHOMJCDNXHFI-UHFFFAOYSA-N COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1
32 P35968_DB12307 DB12307 Foretinib n/a
CXQHYVUVSFXTMY-UHFFFAOYSA-N COC1=C(OCCCN2CCOCC2)C=C2N=CC=C(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3F)C2=C1
33 P35968_DB14840 DB14840 Ripretinib inhibitor
CEFJVGZHQAGLHS-UHFFFAOYSA-N CCN1C(=O)C(=CC2=C1C=C(NC)N=C2)C1=C(Br)C=C(F)C(NC(=O)NC2=CC=CC=C2)=C1
34 P35968_DB15822 DB15822 Pralsetinib inhibitor
GBLBJPZSROAGMF-RWYJCYHVSA-N CO[C@@]1(CC[C@@H](CC1)C1=NC(NC2=NNC(C)=C2)=CC(C)=N1)C(=O)N[C@@H](C)C1=CC=C(N=C1)N1C=C(F)C=N1